|
1
|
Bassan R, Bourquin JP, DeAngelo DJ and
Chiaretti S: New approaches to the management of adult acute
lymphoblastic leukemia. J Clin Oncol. Sep 21–2018.(Epub ahead of
print). JCO2017773648. doi: 10.1200/JCO.2017.77.3648. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brassesco MS, Pezuk JA, Cortez MA, Bezerra
Salomão K, Scrideli CA and Tone LG: TLE1 as an indicator of adverse
prognosis in pediatric acute lymphoblastic leukemia. Leuk Res.
74:42–46. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patrick K and Vora A: Update on biology
and treatment of T-cell acute lymphoblastic leukaemia. Curr Opin
Pediatr. 27:44–9. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matloub Y, Stork L, Asselin B, Hunger SP,
Borowitz M, Jones T, Bostrom B, Gastier-Foster JM, Heerema NA,
Carroll A, et al: Outcome of children with standard-risk T-lineage
acute lymphoblastic leukemia - Comparison among different treatment
strategies. Pediatr Blood Cancer. 63:255–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gaynon PS, Angiolillo AL, Carroll WL,
Nachman JB, Trigg ME, Sather HN, Hunger SP and Devidas M: Long-term
results of the children's cancer group studies for childhood acute
lymphoblastic leukemia 1983–2002: A Children's Oncology Group
Report. Leukemia. 24:285–297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Silverman LB, Stevenson KE, O'Brien JE,
Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C,
Michon B, et al: Long-term results of Dana-Farber Cancer Institute
ALL Consortium protocols for children with newly diagnosed acute
lymphoblastic leukemia (1985–2000). Leukemia. 24:320–334. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang W, Wang WT, Fang K, Chen ZH, Sun YM,
Han C, Sun LY, Luo XQ and Chen YQ: MIR-708 promotes phagocytosis to
eradicate T-ALL cells by targeting CD47. Mol Cancer. 17:122018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
You P, Wu H, Deng M, Peng J, Li F and Yang
Y: Brevilin A induces apoptosis and autophagy of colon
adenocarcinoma cell CT26 via mitochondrial pathway and
PI3K/AKT/mTOR inactivation. Biomed Pharmacother. 98:619–625. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang YH, Sun ZL, Fan MS, Li ZX and Huang
CG: Anti-diabetic effects of TongGuanWan, a Chinese traditional
herbal formula, in C57BL/KsJ-db/db mice. Planta Med. 78:18–23.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee B, Jung K and Kim DH: Timosaponin
AIII, a saponin isolated from Anemarrhena asphodeloides,
ameliorates learning and memory deficits in mice. Pharmacol Biochem
Behav. 93:121–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lim SM, Jeong JJ, Kang GD, Kim KA, Choi HS
and Kim DH: Timosaponin AIII and its metabolite sarsasapogenin
ameliorate colitis in mice by inhibiting NF-κB and MAPK activation
and restoringTh17/Treg cell balance. Int Immunopharmacol.
25:493–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee B, Trinh HT, Jung K, Han SJ and Kim
DH: Inhibitory effects of steroidal timosaponins isolated from the
rhizomes of Anemarrhena asphodeloides against passive
cutaneous anaphylaxis reaction and pruritus. Immunopharmacol
Immunotoxicol. 32:357–363. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang GJ, Lin LC, Chen CF, Cheng JS, Lo YK,
Chou KJ, Lee KC, Liu CP, Wu YY Su W, et al: Effect of Timosaponin
A-III, from Anemarrhenae asphodeloides Bunge (Liliaceae), on
calcium mobilization in vascular endothelial and smooth muscle
cells and on vascular tension. Life Sci. 71:1081–1090. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang HL, Chiang WL, Hsiao PC, Chien MH,
Chen HY, Weng WC, Hsieh MJ and Yang SF: Timosaponin AIII mediates
caspase activation and induces apoptosis through JNK1/2 pathway in
human promyelocytic leukemia cells. Tumour Biol. 36:3489–3497.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lok CN, Sy LK, Liu F and Che CM:
Activation of autophagy of aggregation- prone ubiquitinated
proteins by timosaponin A-III. J Biol Chem. 286:31684–31696. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sy LK, Yan SC, Lok CN, Man RY and Che CM:
Timosaponin A-III induces autophagy preceding mitochondria-mediated
apoptosis in HeLa cancer cells. Cancer Res. 68:10229–10237. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen JR, Jia XH, Wang H, Yi YJ, Wang JY
and Li YJ: Timosaponin A-III reverses multi-drug resistance in
human chronic myelogenous leukemia K562/ADM cells via
downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt
signaling pathway. Int J Oncol. 48:2063–2070. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang YJ, Chung HJ, Nam JW, Park HJ, Seo
EK, Kim YS, Lee D and Lee SK: Cytotoxic and antineoplastic activity
of timosaponin A-III for human colon cancer cells. J Nat Prod.
74:701–706. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nho KJ, Chun JM and Kim HK: Induction of
mitochondria-dependent apoptosis in HepG2 human hepatocellular
carcinoma cells by timosaponin A-III. Environ Toxicol Pharmacol.
45:295–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Biederbick A, Kern HF and Elsasser HP:
Monodansylcadaverine (MDC) is a specific in vivo marker for
autophagic vacuoles. Eur J Cell Biol. 66:3–14. 1995.PubMed/NCBI
|
|
21
|
Kwak CH, Lee SH, Lee SK, Ha SH, Suh SJ,
Kwon KM, Chung TW, Ha KT, Chang YC, Lee YC, et al: Induction of
apoptosis and antitumor activity of eel skin mucus, containing
lactose-binding molecules, on human leukemic K562 cells. Mar Drugs.
13:3936–3949. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scarfò L and Ghia P: Reprogramming cell
death: BCL2 family inhibition in hematological malignancies.
Immunol Lett. 155:36–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qi L, Ren K, Fang F, Zhao DH, Yang NJ and
Li Y: Over expression of BCL2 and low expression of caspase 8
related to TRAIL resistance in brain cancer stem cells. Asian Pac J
Cancer Prev. 16:4849–4852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Christodoulou MI, Kontos CK, Halabalaki M,
Skaltsounis AL and Scorilas A: Nature promises new anticancer
agents: Interplay with the apoptosis-related BCL2 gene family.
Anticancer Agents Med Chem. 14:375–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang S, Zhou M, Ouyang J, Geng Z and Wang
Z: Tetraarsenictetrasulfide and arsenic trioxide exert synergistic
effects on induction of apoptosis and differentiation in acute
promyelocytic leukemia cells. PLoS One. 10:e01303432015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cingeetham A, Vuree S, Dunna NR, Gorre M,
Nanchari SR, Edathara PM, Meka P, Annamaneni S, Digumarthi R, Sinha
S and Satti V: Influence of BCL2-938C>A and BAX-248G>A
promoter polymorphisms in the development of AML: Case-control
study from South India. Tumour Biol. 36:7967–7976. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Glick D, Barth S and Macleod KF:
Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wilde L, Tanson K, Curry J and
Martinez-Outschoorn U: Autophagy in cancer: A complex relationship.
Biochem J. 475:1939–1954. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mizushima N: The pleiotropic role of
autophagy: from protein metabolism to bactericide. Cell Death
Differ. 12 (Suppl 2):S1535–S1541. 2005. View Article : Google Scholar
|
|
30
|
Altman BJ, Jacobs SR, Mason EF, Michalek
RD, MacIntyre AN, Coloff JL, Ilkayeva O, Jia W, He YW and Rathmell
JC: Autophagy is essential to suppress cell stress and to allow
BCR-Abl-mediated leukemogenesis. Oncogene. 30:1855–1867. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gong A, Ye S, Xiong E, Guo W, Zhang Y,
Peng W, Shao G, Jin J, Zhang Z, Yang J, et al: Autophagy
contributes to ING4-induced glioma cell death. Exp Cell Res.
319:1714–1723. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang N, Feng Y, Zhu M, Siu FM, Ng KM and
Che CM: A novel mechanism of XIAP degradation induced by
Timosaponin AIII in hepatocellular carcinoma. Biochim Biophys Acta.
1833:2890–2899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al:
Promotion of tumorigenesis by heterozygous disruption of the
beclin 1 autophagy gene. J Clin Invest. 112:1809–20. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu Y, Cai X, Zong B, Feng R, Ji Y, Chen G
and Li Z: Qianlie Xiaozheng decoction induces autophagy in human
prostate cancer cells via inhibition of the Akt/mTOR pathway. Front
Pharmacol. 9:2342018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin H, Zhang C, Zhang H, Xia YZ, Zhang CY,
Luo J, Yang L and Kong LY: Physakengose G induces apoptosis via
EGFR/mTOR signaling and inhibits autophagic flux in human
osteosarcoma cells. Phytomedicine. 42:190–198. 2018. View Article : Google Scholar : PubMed/NCBI
|
